Inflammatory Myopathy Clinical Trials

26 clinical trials for Inflammatory Myopathy across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy — RECRUITING · PHASE1
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases — RECRUITING · PHASE1
• Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases — RECRUITING · PHASE1
• MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) — RECRUITING
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases — RECRUITING · PHASE1
• BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases — RECRUITING · PHASE2
• Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases — RECRUITING · NA
• An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease — RECRUITING · NA
• UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases — WITHDRAWN · PHASE1
• Virtual Reality and Robotics in Inflammatory Myopathy Rehabilitation — COMPLETED · NA
• TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) — NOT_YET_RECRUITING · PHASE2
• UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Renal Manifestations During Idiopathic Inflammatory Myopathies — OTHER
• The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease — OTHER · NA
• Adult Idiopathic Inflammatory Myopathy With Cardiac Injury — NOT_YET_RECRUITING
• Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation — OTHER · PHASE2
• Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases — OTHER
• Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy — OTHER · PHASE2
• Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy — OTHER · PHASE2
• Yellow Fever Vaccine in Patients With Rheumatic Diseases — COMPLETED · NA
• Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases — COMPLETED

Refine this search